Franklin Resources
JBIO

Franklin Resources’s Jade Biosciences JBIO Stock Holding History

Franklin Resources’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62M Buy
+2,792,080
New +$58.2M 0.01% 607

Other funds holding JBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Franklin Resources's JBIO Position: Q2 2026 in Review

Franklin Resources opened a new position in Jade Biosciences (JBIO) in Q2 2026: 2,792,080 shares worth $62M. The stake represents 0.01% of the portfolio and ranks #607 among its holdings.

81 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Franklin Resources held 2,792,080 shares of Jade Biosciences worth $62M as of Q2 2026.
  • Jade Biosciences was a new Franklin Resources position in Q2 2026.
  • Jade Biosciences made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #607 holding.
  • 81 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.